These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26388462)

  • 41. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW; Mahmoudzadeh R; Kuriyan AE
    Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New best1 mutations in autosomal recessive bestrophinopathy.
    Fung AT; Yzer S; Goldberg N; Wang H; Nissen M; Giovannini A; Merriam JE; Bukanova EN; Cai C; Yannuzzi LA; Tsang SH; Allikmets R
    Retina; 2015 Apr; 35(4):773-82. PubMed ID: 25545482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct expression requirements and rescue strategies for
    Zhao Q; Kong Y; Kittredge A; Li Y; Shen Y; Zhang Y; Tsang SH; Yang T
    Elife; 2021 Jun; 10():. PubMed ID: 34061021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bestrophin 1--Phenotypes and Functional Aspects in Bestrophinopathies.
    Pasquay C; Wang LF; Lorenz B; Preising MN
    Ophthalmic Genet; 2015; 36(3):193-212. PubMed ID: 24328569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration.
    Hartzell C; Qu Z; Putzier I; Artinian L; Chien LT; Cui Y
    Physiology (Bethesda); 2005 Oct; 20():292-302. PubMed ID: 16174869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bestrophin 1 is indispensable for volume regulation in human retinal pigment epithelium cells.
    Milenkovic A; Brandl C; Milenkovic VM; Jendryke T; Sirianant L; Wanitchakool P; Zimmermann S; Reiff CM; Horling F; Schrewe H; Schreiber R; Kunzelmann K; Wetzel CH; Weber BH
    Proc Natl Acad Sci U S A; 2015 May; 112(20):E2630-9. PubMed ID: 25941382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bestrophins and retinopathies.
    Xiao Q; Hartzell HC; Yu K
    Pflugers Arch; 2010 Jul; 460(2):559-69. PubMed ID: 20349192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies.
    Allikmets R; Seddon JM; Bernstein PS; Hutchinson A; Atkinson A; Sharma S; Gerrard B; Li W; Metzker ML; Wadelius C; Caskey CT; Dean M; Petrukhin K
    Hum Genet; 1999 Jun; 104(6):449-53. PubMed ID: 10453731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-Based Therapy for Degenerative Retinal Disease.
    Zarbin M
    Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating BEST1 mutations in pluripotent stem cell-derived retinal pigment epithelial cells.
    Kittredge A; Zhang Y; Yang T
    Methods Enzymol; 2021; 654():365-382. PubMed ID: 34120722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration.
    Pennington BO; Clegg DO
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):261-71. PubMed ID: 26889704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optical Coherence Tomography Examination of the Retinal Pigment Epithelium in Best Vitelliform Macular Dystrophy.
    Qian CX; Charran D; Strong CR; Steffens TJ; Jayasundera T; Heckenlively JR
    Ophthalmology; 2017 Apr; 124(4):456-463. PubMed ID: 28187978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in the molecular basis of inherited photoreceptor degeneration.
    Clarke G; Héon E; McInnes RR
    Clin Genet; 2000 May; 57(5):313-29. PubMed ID: 10852366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pigmented epithelium, a bright partner against photoreceptor degeneration.
    Letelier J; Bovolenta P; Martínez-Morales JR
    J Neurogenet; 2017 Dec; 31(4):203-215. PubMed ID: 29113536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB).
    Gerth C; Zawadzki RJ; Werner JS; Héon E
    Doc Ophthalmol; 2009 Jun; 118(3):239-46. PubMed ID: 18985398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes.
    Milenkovic A; Milenkovic VM; Wetzel CH; Weber BHF
    Hum Mol Genet; 2018 May; 27(9):1630-1641. PubMed ID: 29668979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genetic pathology of the retina].
    Grange JD
    J Genet Hum; 1986 Jan; 34(1):45-60. PubMed ID: 3958699
    [No Abstract]   [Full Text] [Related]  

  • 60. [RPE transplantation: the challenges and the future].
    Boulton ME
    Ophthalmologe; 2004 Sep; 101(9):877-81. PubMed ID: 15448991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.